位置:首页 > 蛋白库 > ACTP1_STIHL
ACTP1_STIHL
ID   ACTP1_STIHL             Reviewed;         176 AA.
AC   P81662; Q9N601;
DT   15-JUL-1999, integrated into UniProtKB/Swiss-Prot.
DT   15-JUL-1999, sequence version 1.
DT   03-AUG-2022, entry version 105.
DE   RecName: Full=DELTA-stichotoxin-She4a {ECO:0000303|PubMed:22683676};
DE            Short=DELTA-SHTX-She4a {ECO:0000303|PubMed:22683676};
DE   AltName: Full=Cytolysin sticholysin I {ECO:0000303|PubMed:11306138};
DE            Short=St I {ECO:0000303|PubMed:10978735};
DE            Short=St-I {ECO:0000303|PubMed:11306138};
DE   AltName: Full=Sticholysin I {ECO:0000303|PubMed:19636934};
DE            Short=Stn I {ECO:0000303|PubMed:19636934};
DE   AltName: Full=Sticholysin-1 {ECO:0000305};
DE            Short=STCH {ECO:0000303|Ref.2};
OS   Stichodactyla helianthus (Sun anemone) (Stoichactis helianthus).
OC   Eukaryota; Metazoa; Cnidaria; Anthozoa; Hexacorallia; Actiniaria;
OC   Stichodactylidae; Stichodactyla.
OX   NCBI_TaxID=6123;
RN   [1]
RP   PROTEIN SEQUENCE, AND MASS SPECTROMETRY.
RX   PubMed=11306138; DOI=10.1016/s0041-0101(00)00247-6;
RA   Huerta V., Morera V., Guanche Y., Chinea G., Gonzalez L.J., Betancourt L.,
RA   Martinez D., Alvarez C., Lanio M.E., Besada V.;
RT   "Primary structure of two cytolysin isoforms from Stichodactyla helianthus
RT   differing in their hemolytic activity.";
RL   Toxicon 39:1253-1256(2001).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 9-176.
RA   de los Rios V., Onaderra M., Martinez del Pozo A., Mancheno J.M.,
RA   Gavilanes J.G.;
RT   "Cloning and expression of sticholysins from sea aemone, Stichodactyla
RT   helianthus.";
RL   Submitted (OCT-2000) to the EMBL/GenBank/DDBJ databases.
RN   [3]
RP   FUNCTION.
RX   PubMed=10978735; DOI=10.1016/s0041-0101(00)00106-9;
RA   Lanio M.E., Morera V., Alvarez C., Tejuca M., Gomez T., Pazos F.,
RA   Besada V., Martinez D., Huerta V., Padron G., Chavez M.A.;
RT   "Purification and characterization of two hemolysins from Stichodactyla
RT   helianthus.";
RL   Toxicon 39:187-194(2001).
RN   [4]
RP   FUNCTION.
RX   PubMed=11478962; DOI=10.1016/s0041-0101(01)00127-1;
RA   Martinez D., Campos A.M., Pazos F., Alvarez C., Lanio M.E., Casallanovo F.,
RA   Schreier S., Salinas R.K., Vergara C., Lissi E.;
RT   "Properties of St I and St II, two isotoxins isolated from Stichodactyla
RT   helianthus: a comparison.";
RL   Toxicon 39:1547-1560(2001).
RN   [5]
RP   MUTAGENESIS OF GLU-16.
RX   PubMed=17067649; DOI=10.1016/j.toxicon.2006.09.004;
RA   Pazos F., Valle A., Martinez D., Ramirez A., Calderon L., Pupo A.,
RA   Tejuca M., Morera V., Campos J., Fando R., Dyszy F., Schreier S.,
RA   Horjales E., Alvarez C., Lanio M.E., Lissi E.;
RT   "Structural and functional characterization of a recombinant sticholysin I
RT   (rSt I) from the sea anemone Stichodactyla helianthus.";
RL   Toxicon 48:1083-1094(2006).
RN   [6]
RP   REVIEW.
RX   PubMed=19268680; DOI=10.1016/j.toxicon.2009.02.026;
RA   Kristan K.C., Viero G., Dalla Serra M., Macek P., Anderluh G.;
RT   "Molecular mechanism of pore formation by actinoporins.";
RL   Toxicon 54:1125-1134(2009).
RN   [7]
RP   NOMENCLATURE.
RX   PubMed=22683676; DOI=10.1016/j.toxicon.2012.05.020;
RA   Oliveira J.S., Fuentes-Silva D., King G.F.;
RT   "Development of a rational nomenclature for naming peptide and protein
RT   toxins from sea anemones.";
RL   Toxicon 60:539-550(2012).
RN   [8]
RP   STRUCTURE BY NMR.
RX   PubMed=19636934; DOI=10.1007/s12104-008-9127-3;
RA   Castrillo I., Alegre-Cebollada J., del Pozo A.M., Gavilanes J.G.,
RA   Santoro J., Bruix M.;
RT   "1H, 13C, and 15N NMR assignments of the actinoporin Sticholysin I.";
RL   Biomol. NMR. Assign. 3:5-7(2009).
CC   -!- FUNCTION: Pore-forming protein that forms cations-selective hydrophilic
CC       pores of around 1 nm and causes cardiac stimulation and hemolysis. Pore
CC       formation is a multi-step process that involves specific recognition of
CC       membrane sphingomyelin (but neither cholesterol nor
CC       phosphatidylcholine) using aromatic rich region and adjacent
CC       phosphocholine (POC) binding site, firm binding to the membrane (mainly
CC       driven by hydrophobic interactions) accompanied by the transfer of the
CC       N-terminal region to the lipid-water interface and finally pore
CC       formation after oligomerization of monomers. Cytolytic effects include
CC       red blood cells hemolysis, platelet aggregation and lysis, cytotoxic
CC       and cytostatic effects on fibroblasts. Lethality in mammals has been
CC       ascribed to severe vasospasm of coronary vessels, cardiac arrhythmia,
CC       and inotropic effects. {ECO:0000269|PubMed:10978735,
CC       ECO:0000269|PubMed:11478962}.
CC   -!- SUBUNIT: Tetramer in the presence of a lipidic interface. Monomer, in
CC       soluble state. {ECO:0000250}.
CC   -!- SUBCELLULAR LOCATION: Secreted. Nematocyst. Target cell membrane
CC       {ECO:0000250}. Note=Forms an alpha-helical membrane channel in the
CC       prey. {ECO:0000250}.
CC   -!- DOMAIN: The N-terminal region, before the pore is formed, is bound to
CC       the lipid membrane. It partitions into the lipid-water interface and
CC       stabilizes the monomeric molecule on the membrane. Finally, it
CC       traverses the bilayer, thus forming the transmembrane pore.
CC       {ECO:0000250|UniProtKB:P61914}.
CC   -!- MASS SPECTROMETRY: Mass=19392; Mass_error=2; Method=Electrospray;
CC       Evidence={ECO:0000269|PubMed:11306138};
CC   -!- SIMILARITY: Belongs to the actinoporin family. Sea anemone subfamily.
CC       {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AJ009931; CAC00651.2; -; Genomic_DNA.
DR   PDB; 2KS4; NMR; -; A=1-176.
DR   PDBsum; 2KS4; -.
DR   AlphaFoldDB; P81662; -.
DR   BMRB; P81662; -.
DR   SMR; P81662; -.
DR   TCDB; 1.C.38.1.2; the pore-forming equinatoxin (equinatoxin) family.
DR   EvolutionaryTrace; P81662; -.
DR   GO; GO:0005576; C:extracellular region; IEA:UniProtKB-SubCell.
DR   GO; GO:0042151; C:nematocyst; IEA:UniProtKB-SubCell.
DR   GO; GO:0046930; C:pore complex; IEA:InterPro.
DR   GO; GO:0015267; F:channel activity; IEA:InterPro.
DR   GO; GO:0090729; F:toxin activity; IEA:UniProtKB-KW.
DR   GO; GO:0006812; P:cation transport; IEA:InterPro.
DR   GO; GO:0044179; P:hemolysis in another organism; IEA:UniProtKB-KW.
DR   GO; GO:0046931; P:pore complex assembly; IEA:InterPro.
DR   Gene3D; 2.60.270.20; -; 1.
DR   InterPro; IPR009104; Anemon_actinoporin-like.
DR   InterPro; IPR015926; Cytolysin/lectin.
DR   Pfam; PF06369; Anemone_cytotox; 1.
DR   SUPFAM; SSF63724; SSF63724; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Cytolysis; Direct protein sequencing; Hemolysis;
KW   Ion transport; Membrane; Nematocyst; Secreted; Target cell membrane;
KW   Target membrane; Toxin; Transmembrane; Transport.
FT   CHAIN           1..176
FT                   /note="DELTA-stichotoxin-She4a"
FT                   /evidence="ECO:0000269|PubMed:11306138"
FT                   /id="PRO_0000221537"
FT   REGION          2..11
FT                   /note="Plays an important role in the hemolytic activity"
FT                   /evidence="ECO:0000250|UniProtKB:P07845"
FT   REGION          10..29
FT                   /note="N-terminal region"
FT                   /evidence="ECO:0000250|UniProtKB:P61914"
FT   REGION          104..119
FT                   /note="Trp-rich region, which is important for the binding
FT                   to lipid membrane"
FT                   /evidence="ECO:0000250|UniProtKB:P61914"
FT   MOTIF           142..144
FT                   /note="Cell attachment site"
FT                   /evidence="ECO:0000255"
FT   BINDING         53
FT                   /ligand="phosphocholine"
FT                   /ligand_id="ChEBI:CHEBI:295975"
FT                   /evidence="ECO:0000250|UniProtKB:P07845"
FT   BINDING         86
FT                   /ligand="phosphocholine"
FT                   /ligand_id="ChEBI:CHEBI:295975"
FT                   /evidence="ECO:0000250|UniProtKB:P07845"
FT   BINDING         104
FT                   /ligand="phosphocholine"
FT                   /ligand_id="ChEBI:CHEBI:295975"
FT                   /evidence="ECO:0000250|UniProtKB:P07845"
FT   BINDING         106
FT                   /ligand="phosphocholine"
FT                   /ligand_id="ChEBI:CHEBI:295975"
FT                   /evidence="ECO:0000250|UniProtKB:P07845"
FT   BINDING         132
FT                   /ligand="phosphocholine"
FT                   /ligand_id="ChEBI:CHEBI:295975"
FT                   /evidence="ECO:0000250|UniProtKB:P07845"
FT   BINDING         136
FT                   /ligand="phosphocholine"
FT                   /ligand_id="ChEBI:CHEBI:295975"
FT                   /evidence="ECO:0000250|UniProtKB:P07845"
FT   BINDING         137
FT                   /ligand="phosphocholine"
FT                   /ligand_id="ChEBI:CHEBI:295975"
FT                   /evidence="ECO:0000250|UniProtKB:P07845"
FT   SITE            111
FT                   /note="Important in the initial contact with the lipid
FT                   membrane"
FT                   /evidence="ECO:0000250|UniProtKB:P61914"
FT   SITE            112
FT                   /note="Important in the initial contact with the lipid
FT                   membrane"
FT                   /evidence="ECO:0000250|UniProtKB:P61914"
FT   SITE            142
FT                   /note="Interacts with the lipid membrane"
FT                   /evidence="ECO:0000250"
FT   MUTAGEN         16
FT                   /note="E->Q: Shows larger hemolytic activity in human red
FT                   blood cells, but no change in capacity to form pore."
FT                   /evidence="ECO:0000269|PubMed:17067649"
FT   TURN            10..12
FT                   /evidence="ECO:0007829|PDB:2KS4"
FT   HELIX           15..24
FT                   /evidence="ECO:0007829|PDB:2KS4"
FT   STRAND          28..38
FT                   /evidence="ECO:0007829|PDB:2KS4"
FT   STRAND          40..42
FT                   /evidence="ECO:0007829|PDB:2KS4"
FT   STRAND          44..50
FT                   /evidence="ECO:0007829|PDB:2KS4"
FT   STRAND          52..54
FT                   /evidence="ECO:0007829|PDB:2KS4"
FT   STRAND          62..64
FT                   /evidence="ECO:0007829|PDB:2KS4"
FT   STRAND          68..75
FT                   /evidence="ECO:0007829|PDB:2KS4"
FT   STRAND          77..82
FT                   /evidence="ECO:0007829|PDB:2KS4"
FT   STRAND          84..93
FT                   /evidence="ECO:0007829|PDB:2KS4"
FT   TURN            94..96
FT                   /evidence="ECO:0007829|PDB:2KS4"
FT   STRAND          97..105
FT                   /evidence="ECO:0007829|PDB:2KS4"
FT   TURN            109..111
FT                   /evidence="ECO:0007829|PDB:2KS4"
FT   STRAND          117..124
FT                   /evidence="ECO:0007829|PDB:2KS4"
FT   HELIX           129..136
FT                   /evidence="ECO:0007829|PDB:2KS4"
FT   TURN            153..155
FT                   /evidence="ECO:0007829|PDB:2KS4"
FT   STRAND          156..161
FT                   /evidence="ECO:0007829|PDB:2KS4"
FT   STRAND          164..167
FT                   /evidence="ECO:0007829|PDB:2KS4"
FT   STRAND          170..174
FT                   /evidence="ECO:0007829|PDB:2KS4"
SQ   SEQUENCE   176 AA;  19391 MW;  4879B6C5A3547B62 CRC64;
     SELAGTIIDG ASLTFEVLDK VLGELGKVSR KIAVGIDNES GGTWTALNAY FRSGTTDVIL
     PEVVPNTKAL LYSGRKSSGP VATGAVAAFA YYMSNGNTLG VMFSVPFDYN WYSNWWDVKI
     YPGKRRADQG MYEDMYYGNP YRGDNGWYQK NLGYGLRMKG IMTSAGEAKM QIKISR
 
 
维奥蛋白资源库 - 中文蛋白资源 CopyRight © 2010-2024